AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 162 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,142,287 | +12.4% | 46,153 | +28.6% | 0.00% | 0.0% |
| Q2 2023 | $1,016,461 | +78.5% | 35,892 | +42.1% | 0.00% | – |
| Q1 2023 | $569,590 | -1.3% | 25,259 | +23.0% | 0.00% | – |
| Q4 2022 | $576,847 | +137.4% | 20,543 | +139.1% | 0.00% | – |
| Q3 2022 | $243,000 | -83.9% | 8,592 | -81.5% | 0.00% | -100.0% |
| Q3 2019 | $1,506,000 | -74.7% | 46,472 | -61.1% | 0.00% | -66.7% |
| Q2 2019 | $5,962,000 | -20.7% | 119,526 | +7.2% | 0.01% | -25.0% |
| Q1 2019 | $7,521,000 | +67.5% | 111,526 | +14.5% | 0.01% | +60.0% |
| Q4 2018 | $4,490,000 | -17.0% | 97,366 | +16.9% | 0.01% | -16.7% |
| Q4 2015 | $5,409,000 | -56.0% | 83,316 | -52.2% | 0.01% | -60.0% |
| Q3 2015 | $12,303,000 | -36.5% | 174,286 | -0.0% | 0.02% | -31.8% |
| Q2 2015 | $19,371,000 | +1909.4% | 174,296 | +1605.1% | 0.02% | +2100.0% |
| Q1 2015 | $964,000 | -16.4% | 10,222 | -0.7% | 0.00% | 0.0% |
| Q4 2014 | $1,153,000 | +100.9% | 10,293 | +10.1% | 0.00% | 0.0% |
| Q3 2014 | $574,000 | – | 9,351 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 965,369 | $56,378,000 | 14.98% |
| Casdin Capital, LLC | 237,500 | $13,870,000 | 8.18% |
| BB BIOTECH AG | 2,839,528 | $165,828,000 | 5.42% |
| Opaleye Management Inc. | 130,000 | $7,592,000 | 3.78% |
| Redmile Group, LLC | 902,578 | $52,711,000 | 3.42% |
| Clarius Group, LLC | 109,230 | $6,379,000 | 2.63% |
| Opus Point Partners Management, LLC | 57,410 | $3,353,000 | 2.49% |
| Ghost Tree Capital, LLC | 125,000 | $7,300,000 | 1.36% |
| CAPITAL INTERNATIONAL LTD /CA/ | 346,937 | $20,261,000 | 1.32% |
| Eventide Asset Management | 300,800 | $17,567,000 | 1.16% |